Trends in Allogeneic Stem Cell Transplantation for Good Risk Acute Myelogenous Leukemia in First Complete Remission: A Longitudinal Study of > 15 Years from the ALWP/EBMT

被引:0
作者
Nagler, Arnon [1 ]
Labopin, Myriam [2 ]
Salmenniemi, Urpu [3 ]
Wu, Depei [4 ]
Blaise, Didier [5 ]
Rambaldi, Alessandro [6 ,7 ]
Remenyi, Peter [8 ]
Forcade, Edouard [9 ]
De latour, Regis Peffault [10 ]
Chevallier, Patrice [11 ]
von dem Borne, Peter, Sr. [12 ]
Burns, David [13 ]
Schmid, Christoph [14 ]
Maertens, Johan [15 ]
Kroeger, Nicolaus [16 ]
Bug, Gesine [17 ]
Aljurf, Mahmoud [18 ]
Vydra, Jan [19 ]
Halaburda, Kazimierz [20 ]
Ciceri, Fabio [21 ]
Mohty, Mohamad [22 ,23 ]
机构
[1] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Tel Hashomer, Israel
[2] Sorbonne Univ, St Antoine Hosp, AP HP, EBMT Stat Unit,INSERM,UMRs 938, Paris, France
[3] HUCH Comprehens Canc Ctr, Stem Cell Transplantat Unit, Helsinki, Finland
[4] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
[5] Inst Paoli Calmettes, Dept Hematol, Program Transplant & Cellular Immunotherapy, Marseille, France
[6] Univ Milan, Dept Oncol & Hematol, Bergamo, Italy
[7] Azienda Sociosanit Terr Papa Giovanni XXIII, Bergamo, Italy
[8] South Pest Cent Hosp, Dept Hematol & Stem Cell Transplantat, Budapest, Hungary
[9] CHU Bordeaux, Serv Hematol Clin & Therapie Cellulaire, F-33000 Bordeaux, France
[10] Hop St Louis, Paris, France
[11] CHU Nantes, Nantes 1, France
[12] Leiden Univ, Med Ctr, Leiden, Netherlands
[13] Univ Hosp Birmingham NHS Trust, Stoke, Birmingham, W Midlands, England
[14] Klinikum Augsburg, Augsburg, Ghana
[15] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium
[16] Univ Hosp Eppendorf, Bone Marrow Transplantat Ctr, Hamburg, Germany
[17] Klin Innere Med III, Ulm, Germany
[18] KFSHRC, Dept Hematol Stem Cell Transplantat & Cellular Th, Riyadh, Saudi Arabia
[19] Inst Hematol & Blood Transfus, Prague 10, Czech Republic
[20] Inst Hematol & Transfus Med, Warsaw, Poland
[21] Univ Vita Salute San Raffaele, IRCCS Osped San Raffaele, Milan, Italy
[22] Sorbonne Univ, St Antoine Hosp, Paris, France
[23] Hop St Antoine, Paris, France
关键词
D O I
10.1182/blood-2023-174599
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Comparison of Matched/Mismatched Unrelated Donor Stem Cell Transplantation to Autologous Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: A Study from the Acute Leukemia Working Party of the EBMT
    Saraceni, F.
    Labopin, M.
    Gorin, N. -C.
    Blaise, D.
    Tabrizi, R.
    Volin, L.
    Cornelissen, J.
    Cahn, J. -Y.
    Chevallier, P.
    Craddock, C.
    Depei, W.
    Huynh, A.
    Arcese, W.
    Mohty, M.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S7 - S8
  • [22] Allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia in other than first complete remission status
    Alimoghaddam, K.
    Khatami, F.
    Jalali, A.
    Jahani, M.
    Mousavi, S.
    Iravani, M.
    Khodabandeh, A.
    Bahar, B.
    Alimohammadi, A.
    Bahar, N.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S382 - S382
  • [23] SECOND ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT2) FOR PRIMARY GRAFT FAILURE IN PATIENTS WITH ACUTE LEUKEMIA IN REMISSION: ON BEHALF OF THE ALWP OF THE EBMT
    Nagler, Arnon
    Labopin, Myriam
    Kulagin, Aleksandr
    Velardi, Andrea
    Sanz, Jaime
    Labussiere-Wallet, Helene
    Potter, Victoria
    Kuball, Jurgen
    Sica, Simona
    Parovichnikova, Elena
    Bethge, Wolfgang
    Leleu, Xavier
    Platzbecker, Uwe
    Stoelzel, Friedrich
    Ciceri, Fabio
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 154 - 154
  • [24] EBMT ALWP study: myeloablative versus reduced intensity conditioning allogeneic haematopoietic stem cell transplantation in patients with acute myeloid leukaemia in second complete remission
    Gilleece, Maria
    Labopin, Myriam
    Yakoub-Agha, Ibrahim
    Socie, Gerard
    Gedde-Dahl, Tobias
    Blaise, Didier
    Russell, Nigel H.
    Craddock, Charles
    Cornelissen, Jan. J.
    Arcese, William
    Forcade, Edouard
    Crawley, Charles
    ' Polge, Emanuelle
    Mohty, Mohamad
    Savani, Bipin
    Nagler, Arnon
    BONE MARROW TRANSPLANTATION, 2018, 53 : 19 - 20
  • [25] Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT
    Brands-Nijenhuis, Angelique V. M.
    Labopin, Myriam
    Schouten, Harry C.
    Volin, Liisa
    Socie, Gerard
    Cornelissen, Jan J.
    Huynh, Anne
    Ljungman, Per
    Malard, Florent
    Esteve, Jordi
    Nagler, Arnon
    Mohty, Mohamad
    HAEMATOLOGICA, 2016, 101 (02) : 248 - 255
  • [26] Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
    Waidhauser, Johanna
    Labopin, Myriam
    Esteve, Jordi
    Kroger, Nicolaus
    Cornelissen, Jan
    Gedde-Dahl, Tobias
    Van Gorkom, Gwendolyn
    Finke, Jurgen
    Rovira, Montserrat
    Schaap, Nicolaas
    Petersen, Eefke
    Beelen, Dietrich
    Bunjes, Donald
    Savani, Bipin
    Schmid, Christoph
    Nagler, Arnon
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2021, 56 (10) : 2445 - 2453
  • [27] Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT
    Johanna Waidhauser
    Myriam Labopin
    Jordi Esteve
    Nicolaus Kröger
    Jan Cornelissen
    Tobias Gedde-Dahl
    Gwendolyn Van Gorkom
    Jürgen Finke
    Montserrat Rovira
    Nicolaas Schaap
    Eefke Petersen
    Dietrich Beelen
    Donald Bunjes
    Bipin Savani
    Christoph Schmid
    Arnon Nagler
    Mohamad Mohty
    Bone Marrow Transplantation, 2021, 56 : 2445 - 2453
  • [28] Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC
    Malard, Florent
    Labopin, Myriam
    Cho, Christina
    Blaise, Didier
    Papadopoulos, Esperanza B.
    Passweg, Jakob
    O'Reilly, Richard
    Forcade, Edouard
    Maloy, Molly
    Volin, Liisa
    Castro-Malaspina, Hugo
    Hicheri, Yosr
    Jakubowski, Ann A.
    Orvain, Corentin
    Giralt, Sergio
    Mohty, Mohamad
    Nagler, Arnon
    Perales, Miguel-Angel
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [29] Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC
    Florent Malard
    Myriam Labopin
    Christina Cho
    Didier Blaise
    Esperanza B. Papadopoulos
    Jakob Passweg
    Richard O’Reilly
    Edouard Forcade
    Molly Maloy
    Liisa Volin
    Hugo Castro-Malaspina
    Yosr Hicheri
    Ann A. Jakubowski
    Corentin Orvain
    Sergio Giralt
    Mohamad Mohty
    Arnon Nagler
    Miguel-Angel Perales
    Journal of Hematology & Oncology, 11
  • [30] Equivalent Outcome Between Older Siblings and Unrelated Donors After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Patients Older Than 50 Years with Acute Myeloid Leukemia in First Complete Remission: A Report From the ALWP of EBMT
    de Latour, Regis Peffault
    Labopin, Myriam
    Cornelissen, Jan
    Vindelov, Lars
    Blaise, Didier
    Milpied, Noel
    Huyn, Anne
    Craddock, Charles F.
    Russel, Nigel
    Koza, Vladimir
    Lioure, Bruno
    Schouten, Richard
    Caballero, Dolores
    Cahn, Jean-Yves
    Fegueux, Nathalie
    Mohty, Mohamad
    BLOOD, 2012, 120 (21)